[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
Apr 23, 2012

A New Era in Stroke Prevention for Atrial FibrillationComment on “Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation

Author Affiliations

Author Affiliations: Clinical Epidemiology Unit, Division of General Medicine, Massachusetts General Hospital, Boston (Dr Singer); and Division of Research, Kaiser Permanente Northern California, Oakland (Dr Go).

Arch Intern Med. 2012;172(8):631-633. doi:10.1001/archinternmed.2012.897
First Page Preview View Large
First page PDF preview
First page PDF preview
×